Orchid Pharma share price was locked at 20 percent upper circuit at Rs 21.45 on Thursday after approval from the US health regulator for API facility in Tamil Nadu. There were pending buy orders of ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈